Previous studies of PrP in breast cancer are generally consistent with the notion that PrP expression increases the resistance to cytotoxicity [11], [15], [16], [17], [18], indicating that reducing PrP expression could potentially enhance the efficiency of chemotherapy. Here, PRNP is linked to breast cancer.